Cigna Group $CI Stock Sold by Parallel Advisors LLC

Parallel Advisors LLC lowered its holdings in shares of Cigna Group (NYSE:CI) by 45.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,216 shares of the health services provider’s stock after selling 2,678 shares during the quarter. Parallel Advisors LLC’s holdings in Cigna Group were worth $874,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. BlackRock Inc. raised its position in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after purchasing an additional 840,098 shares during the last quarter. GQG Partners LLC acquired a new stake in shares of Cigna Group in the second quarter worth approximately $1,628,918,000. Bank of America Corp DE increased its position in shares of Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after purchasing an additional 256,677 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Cigna Group by 10.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after purchasing an additional 236,340 shares in the last quarter. Finally, Legal & General Group Plc acquired a new position in Cigna Group in the 2nd quarter valued at $542,779,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Recent coverage says strong Q3 growth has lifted Cigna’s 2026 earnings outlook, offering a favorable signal about business performance and the company’s earnings trajectory. The Cigna Group stock: Higher outlook follows strong Q3 performance
• Positive Sentiment: Barclays raised its price target to $320 from $310, implying potential upside from the referenced $302.30 price. However, it maintained an “equal weight” rating, indicating a balanced rather than strongly bullish view. Barclays price target update
• Neutral Sentiment: The Cigna Group Foundation awarded $3.45 million to 23 nonprofits supporting housing stability and mental health for veterans and their families. This highlights community investment but is not likely to have a significant direct effect on earnings. Cigna Foundation veteran grants
• Neutral Sentiment: Cigna’s CFO is scheduled to speak at the UBS Global Healthcare Conference, which could provide investors with updates but is not itself a financial announcement. UBS Global Healthcare Conference appearance
• Neutral Sentiment: Cigna Healthcare Hong Kong is expanding access to Headspace’s self-guided mental-wellbeing resources. The partnership may support its service offering, though the report provides no financial impact. Headspace resources in Hong Kong
• Negative Sentiment: Guggenheim cut its price target for Cigna, a cautious counterpoint to Barclays’ increase. The report provided here does not specify the revised target or rating. Guggenheim price target update

Analyst Ratings Changes

CI has been the topic of a number of research reports. Piper Sandler restated an “overweight” rating on shares of Cigna Group in a report on Friday, October 23rd. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Sanford C. Bernstein reissued an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. Cantor Fitzgerald restated an “overweight” rating and issued a $340.00 price target on shares of Cigna Group in a research note on Friday, November 6th. Finally, Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Fourteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $336.20.

Cigna Group Stock Performance

CI stock opened at $302.30 on Wednesday. The stock’s 50 day simple moving average is $286.66 and its 200 day simple moving average is $282.38. Cigna Group has a 12-month low of $257.85 and a 12-month high of $318.05. The firm has a market cap of $79.88 billion, a P/E ratio of 13.34, a P/E/G ratio of 1.10 and a beta of 0.25. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating the consensus estimate of $7.52 by $0.46. The company had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The business’s revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the company earned $7.83 earnings per share. As a group, equities research analysts predict that Cigna Group will post 30.70 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is currently 27.54%.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.